The University of Texas MD Anderson Cancer Center today announced an agreement to become a Women’s Cancer Partner with the Union for International Cancer Control (UICC), marking a significant collaboration to improve breast and cervical cancer care worldwide. In this capacity, MD Anderson will actively participate in UICC’s initiatives aimed at addressing women’s cancers, with a focus on strategic development, knowledge-sharing and global...
Researchers from The University of Texas MD Anderson Cancer Center demonstrated that adding metastasis-directed radiation therapy...
The University of Texas MD Anderson Cancer Center today announced the further expansion of its global oncology efforts by signing a memorandum...
Pharmacologist V. Craig Jordan, Ph.D., a professor of Breast Medical Oncology and Molecular and Cellular Oncology at The University of Texas MD Anderson Cancer Center who discovered Selective Estrogen Receptor Modulators (SERMs) and developed breakthrough breast cancer treatments, died June 9, 2024, at his home in Houston. He was 76 years old.
Known as the “father of tamoxifen,” Jordan showed that the drug, originally created to...
ABSTRACTS: 3000 and 3005
Two early-phase clinical trials presented at the 2024 American Society of Clinical Oncology (ASCO) Annual...
The University of Texas MD Anderson Cancer Center and the Pan American Health Organization (PAHO) today announced the signing of an agreement...
The University of Texas MD Anderson Cancer Center and RUSH University System for Health today announced a partnership to create RUSH MD Anderson...
Researchers at The University of Texas MD Anderson Cancer Center showed that altering the sequence of breast cancer treatment to administer...
Padmanee Sharma, M.D., Ph.D., associate vice president of Immunobiology, professor of Genitourinary Medical Oncology and Immunology, and director...
The University of Texas MD Anderson Cancer Center today announced the signing of an agreement with the International Atomic Energy Agency...